adropin ENHO peptide
Selected indexed studies
- Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis. (Sci Transl Med, 2024) [PMID:38536934]
- Adropin expression reflects circadian, lipoprotein, and mitochondrial processes in human tissues. (Mol Metab, 2025) [PMID:40578684]
- Adropin deficiency worsens TNBS-induced colitis. (Int Immunopharmacol, 2023) [PMID:37688913]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis. (2024) pubmed
- Adropin expression reflects circadian, lipoprotein, and mitochondrial processes in human tissues. (2025) pubmed
- Adropin deficiency worsens TNBS-induced colitis. (2023) pubmed
- Serum adropin level and ENHO gene expression in systemic sclerosis. (2016) pubmed
- Role of the Unique Secreted Peptide Adropin in Various Physiological and Disease States. (2024) pubmed
- A novel peptide adropin in cardiovascular diseases. (2016) pubmed
- Enho Mutations Causing Low Adropin: A Possible Pathomechanism of MPO-ANCA Associated Lung Injury. (2016) pubmed
- Adropin: a new regulatory peptide in cardiovascular endocrinology. (2014) pubmed
- ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus. (2018) pubmed
- Low-dose adropin stimulates inflammasome activation of macrophage via mitochondrial ROS involved in colorectal cancer progression. (2023) pubmed